🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hiroshi Nishiyama

Eli Lilly (United States)

ORCID: 0000-0001-5034-5777

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction”.

Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction

Diabetes Obesity and Metabolism(2025)10.1111/dom.70063

N/A

0.416DataRank · unranked

8 citations

Alastair W. Knights, Éric Ravussin, Guillermo Sánchez‐Delgado, Hiroshi Nishiyama, Hui‐Rong Qian +6 more

Granule Cells Constitute One of the Major Neuronal Subtypes in the Molecular Layer of the Posterior Cerebellum

eNeuro(2022)10.1523/eneuro.0289-21.2022

N/A

0DataRank · unranked

9 citations

K.Madhukar Reddy, Hiroichi Yoshida, Naoko Nishiyama, Boris V. Zemelman, Hiroshi Nishiyama +1 more

Loss of Purkinje cells in the developing cerebellum strengthens the cerebellothalamic synapses

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.01.564864

N/A

0DataRank · unranked

2 citations

Naoko Nishiyama, Boris V. Zemelman, Hiroshi Nishiyama